Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab plus Nivolumab with Cryotherapy in Soft Tissue Sarcoma
NCT04118166Phase 2Completed
- Start
- Oct 2019
- Primary completion
- Jan 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ipilimumab, nivolumab in soft tissue sarcoma (STS). Started Oct 2019; status: completed.
02
Drugs
ipilimumabnivolumab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04118166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118166.